In This Issue

Total Page:16

File Type:pdf, Size:1020Kb

Load more

21 EMBL June 2004 &cetera Newsletter of the European Molecular Biology Laboratory EMBL and DESY extend collaboration Lab Day-and-a-half 2004... page 3 Kevin Leonard rides off into retirement... page 6 EMBL and DESY renew their vows New website spans EMBL and the Deutsches Elektronen-Synchrotron (DESY) have signed an agree- ment building on our 30-year track record of successful cooperation, continuing EMBL Units the partnership into 2015. A key component in the future collaboration is to A new portal has been launched to upgrade the PETRA ring into a dedicated synchrotron radiation source (begin- p rovide better access to re s e a rc h , ning in 2007). This will maintain EMBL and DESY’s global competitiveness in the services and training across EMBL’s field. The two organizations will also continue to collaborate on research and five sites, and to present more infor- development projects and organize seminars, symposia, workshops and other mation about news and events at the scientific events. Pictured above (left) are Chairman of the DESY Board of Lab. Major goals with the “umbrella Directors Albrecht Wagner and EMBL Director General Fotis C. Kafatos at the site” are to standardize the design official signing of the agreement in Hamburg on May 19, 2004. across the Lab and increase function- ality. Check it out at www.embl.org Chemical Genomics facility set to open on page 5 In cooperation with the German Cancer Research Centre (DKFZ), EMBL has established a Chemical Genomics facility. By July, according to facility head Joe Lewis, everything should be ready to perform the first screens. Like EMBL’s Annual Report out now other core facilities, it will provide services to scientific groups from across the What’s the real story behind the EMBL lab, including small-molecule screening, hit validation and high-throughput logo? How did EMBL research change assay development. on page 2 Swiss watch-making forever? What’s the connection between Barbra Streisand and medaka development? The answers can be found in this year’s Annual Report, Lab Day 2004: from protein crystals to hard rock available now from OIPA ([email protected]). This year’s Lab Day expanded to fill a day and a half of festivities, starting with graduation ceremonies for EMBL’s International PhD Programme, then skip- ping along to poster sessions, postdoc talks and concerts by EMBL’s talented musicians. If anyone finds a box of cereal with a picture of Walter Witke on it, in this issue... please return it to Monterotondo because this crucial component of his group’s poster display was mistakenly thrown away (after the contents were eaten?) by chemical genomics 2 the cleaning staff. on page 3 lab day 2004 3 www.embl.org 5 Groundbreaking ceremony held for PSB names to faces 6 On June 8 EMBL, the ESRF, ILL and IBS celebrated the start of construction on the EMBO corner 7 the new building for the Partnership for Structural Biology in Grenoble. The new science for teachers 7 facility will host over 60 scientists from the partner institutes and will house the core infrastructure for high-throughput protein expression, characterization and news & events 9 crystallization. This will include a Biological Deuterium Labeling Facility which will improve the quantity and quality of research that can be carried out using people@EMBL 10 ILL’s neutron facilities. The ESRF is also constructing a new, highly-automated dual station beamline for macromolecular crystallography. EMBL&cetera Issue 21 - June 2004 New Chemical Genomics facility to provide unique touch to EMBL In cooperation with the German Cancer The result is a collaboration with the chem- EMBL has a very strong track record in Research Centre (DKFZ), EMBL has estab- istry company Tripos Discovery Research molecular biology and has made significant lished a Chemical Genomics facility, on the (TDR), whose chemistry labs are based in contributions to chemistry, but until recently fourth floor of the Heidelberg laboratory, the UK. TDR will provide the screening has not had all the in-house expertise to headed by Joe Lewis. Silke Schumacher, library consisting of approximately 50,000 develop small molecules. Carrying out proj- EMBL's Cooperation Manager, helped to molecules designed to be medicinally rele- ects in the past has required collaborating establish the joint effort between DKFZ and vant, and “follow-upable” to minimize proj- with an external chemistry group. “If you EMBL. By July, Joe says, the facility should ect attrition at later stages in the discovery couldn’t find somebody working on the be ready to perform its first screens. Like p rocess. In addition, TDR will pro v i d e same question, you were out of luck,” Joe EMBL’s other core facilities, it will provide design and synthesis expertise and access to says. “And many projects our researchers services to scientific groups from across the their extensive chemistry knowledge base to wanted to pursue weren’t attractive to phar- lab, including small-molecule screening, hit support chemical optimization of candidate ma or biotech, because they concerned very validation and high-throughput assay molecules that are identified in collaboration basic questions with no clear pay-off.” development. with the research groups. In cases where a collaboration did get off the Establishing a chemical genomics unit in an ground, there was another constraint: work academic setting is unusual, Joe says, at least had to be done on the basis of material trans- for Europe. Of all the types of “omics” out fer agreements, typically with pharmaceuti- there, Chemical Genomics is probably the cal companies. That meant that intellectual one most associated with industry, drug dis- property developed during projects belong- c o v e r y, and applied science. Conducting ed to the company, rather than EMBL. Now, high-throughput screens has been expen- intellectual property arising from work in sive, time-consuming, and difficult. While the facility will benefit the Laboratory. some universities in the US, for example, The facility staff will assist groups in the have created such facilities, EMBL’s unit is development of primary and secondary one of the forerunners in Europe. assays to screen against compound libraries, “This interdisciplinary setup combining then guide them through the process of molecular biology with chemistry gives Joe Lewis, Chemical Genomics facility head developing tool compounds for specific tar- EMBL the chance to create new cutting-edge gets. “This can be done in a cost-effective It’s definitely a worthwhile effort, according research tools for the life sciences,“ says way, opening up new avenues both for basic to Joe – one that fits well into EMBL’s plans Christian Boulin, Head of Core Facilities. research and potential therapeutic applica- for the future. “Small molecules play essen- “The new facility will be very helpful in ful- tions,” Joe says. tial roles in many areas of basic research and filling one of EMBLEM’s major goals: the A successful project needs to be carried out are often used to address important biologi- translation of EMBL’s research results into in stages, he says – typically a limited first new effective pharmaceuticals,” adds cal questions – we’ve seen a steady increase round of screening needs to be carried out to EMBLEM´s Deputy Managing Dire c t o r in the need for such services. Our DKFZ col- determine whether a project is worth pursu- Martin Raditsch. EMBLEM, the technology laborators will focus on finding small mole- ing and if further commitments should be transfer company of EMBL, used its net- cules that modulate cancer related pathways made. The staff has the expertise to help works and know-how to help pull all the and processes. Scientists at EMBL will now re s e a rch ers make these decisions. If you pieces together for the successful launch of be in a better position to develop their own have an idea for a project, stop by the facili- the facility. valuable tools for systems biology research.” ty and speak with Joe. Life Sciences and the Developing World: How much do we care? EMBL Science and A Science and Society minisymposium took tend to be so much more striking than their could cover but a limited number of the place at EMBL-Heidelberg in the afternoon similarities. But, leaving such terminology complex and important issues relating to it. of Friday, June 4. Topics of past meetings problems aside, the basic issue raised from The meeting unfolded along two basic per- have included “stem cells – their origins and different points of view by speakers and spectives: the meaning and viability of medical uses,” “ownership and commercial- panelists concerned the re l a t i o n s h i p doing life sciences in economically under- ization of science,” and “changing publish- between the life sciences on one hand, and privileged social settings, and, second, the ing practices in science.” Responding to the social and economic settings within possibility of influencing and directing the repeatedly expressed interest within the sci- which they are embedded, or, for some rea- life sciences in the more privileged settings entific community at EMBL, this time “Life son fail to get embedded, on the other. When so that the useful knowledge and technolo- Sciences and the Developing World” was we take into account the most appalling of gies that come out of them are more aligned chosen as the main theme. the problems plaguing the world communi- and tuned to the needs of people in the poor- Evidently, it was not so much the compo- t y, the unequal distribution of economic er parts of the world. nents of the main title, “Life Sciences” and resources, it should not come as a surprise to The first session of the symposium consisted “the Developing World,” that gained most anyone that the life sciences are abundantly of talks by three keynote speakers.
Recommended publications
  • Annual Scientific Report 2013 on the Cover Structure 3Fof in the Protein Data Bank, Determined by Laponogov, I

    Annual Scientific Report 2013 on the Cover Structure 3Fof in the Protein Data Bank, Determined by Laponogov, I

    EMBL-European Bioinformatics Institute Annual Scientific Report 2013 On the cover Structure 3fof in the Protein Data Bank, determined by Laponogov, I. et al. (2009) Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nature Structural & Molecular Biology 16, 667-669. © 2014 European Molecular Biology Laboratory This publication was produced by the External Relations team at the European Bioinformatics Institute (EMBL-EBI) A digital version of the brochure can be found at www.ebi.ac.uk/about/brochures For more information about EMBL-EBI please contact: [email protected] Contents Introduction & overview 3 Services 8 Genes, genomes and variation 8 Molecular atlas 12 Proteins and protein families 14 Molecular and cellular structures 18 Chemical biology 20 Molecular systems 22 Cross-domain tools and resources 24 Research 26 Support 32 ELIXIR 36 Facts and figures 38 Funding & resource allocation 38 Growth of core resources 40 Collaborations 42 Our staff in 2013 44 Scientific advisory committees 46 Major database collaborations 50 Publications 52 Organisation of EMBL-EBI leadership 61 2013 EMBL-EBI Annual Scientific Report 1 Foreword Welcome to EMBL-EBI’s 2013 Annual Scientific Report. Here we look back on our major achievements during the year, reflecting on the delivery of our world-class services, research, training, industry collaboration and European coordination of life-science data. The past year has been one full of exciting changes, both scientifically and organisationally. We unveiled a new website that helps users explore our resources more seamlessly, saw the publication of ground-breaking work in data storage and synthetic biology, joined the global alliance for global health, built important new relationships with our partners in industry and celebrated the launch of ELIXIR.
  • The HUPO Proteomics Standards Initiative Meeting: Towards Common Standards for Exchanging Proteomics Data Hinxton, Cambridge, UK, 19–20 October 2002

    The HUPO Proteomics Standards Initiative Meeting: Towards Common Standards for Exchanging Proteomics Data Hinxton, Cambridge, UK, 19–20 October 2002

    Comparative and Functional Genomics Comp Funct Genom 2003; 4: 16–19. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/cfg.232 Feature Meeting Review: The HUPO Proteomics Standards Initiative meeting: towards common standards for exchanging proteomics data Hinxton, Cambridge, UK, 19–20 October 2002 Sandra Orchard, Paul Kersey, Henning Hermjakob* and Rolf Apweiler EMBL Outstation–European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK *Correspondence to: Abstract Henning Hermjakob, EMBL Outstation–European The Proteomics Standards Initiative (PSI) aims to define community standards Bioinformatics Institute, for data representation in proteomics and to facilitate data comparison, exchange Wellcome Trust Genome and verification. Initially the fields of protein–protein interactions (PPI) and mass Campus, Hinxton, Cambridge, spectroscopy have been targeted and the inaugural meeting of the PSI addressed the UK. questions of data storage and exchange in both of these areas. The PPI group rapidly E-mail: reached consensus as to the minimum requirements for a data exchange model; an [email protected] XML draft is now being produced. The mass spectroscopy group have achieved major advances in the definition of a required data model and working groups are currently taking these discussions further. A further meeting is planned in January 2003 to Received: 14 November 2002 advance both these projects. Copyright 2003 John Wiley & Sons, Ltd. Accepted: 14 November 2002 Keywords: proteomics; spectroscopy; protein–protein interactions Introduction process, before splitting into two working parties to address the issues facing their respective fields. The Proteomics Standards Initiative was estab- lished following a meeting in April 2002, jointly organized by HUPO and NAS, at which the urgent Protein–protein interactions (PPI) group need for standardization of proteomics data was recognized.
  • The European Bioinformatics Institute in 2020: Building a Global Infrastructure of Interconnected Data Resources for the Life Sciences Charles E

    The European Bioinformatics Institute in 2020: Building a Global Infrastructure of Interconnected Data Resources for the Life Sciences Charles E

    Published online 8 November 2019 Nucleic Acids Research, 2020, Vol. 48, Database issue D17–D23 doi: 10.1093/nar/gkz1033 The European Bioinformatics Institute in 2020: building a global infrastructure of interconnected data resources for the life sciences Charles E. Cook *, Oana Stroe, Guy Cochrane ,EwanBirney and Rolf Apweiler European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK Received September 21, 2019; Revised October 18, 2019; Editorial Decision October 21, 2019; Accepted November 06, 2019 ABSTRACT ature. EMBL-EBI’s data resources collate, integrate, curate and make freely available to the public the world’s scientific Data resources at the European Bioinformatics In- data. stitute (EMBL-EBI, https://www.ebi.ac.uk/)archive, Our resources (www.ebi.ac.uk/services) include archival organize and provide added-value analysis of re- or deposition databases that store primary experimental search data produced around the world. This year’s data submitted by researchers, as well as knowledgebases update for EMBL-EBI focuses on data exchanges that integrate and add value to experimental data, with among resources, both within the institute and with many having both functions (1,2). All EMBL-EBI data re- a wider global infrastructure. Within EMBL-EBI, data sources, are open access and freely available to any user resources exchange data through a rich network of worldwide at any time, and EMBL-EBI strongly supports data flows mediated by automated systems. This net- the concept of FAIR data (findable, accessible, interopera- work ensures that users are served with as much ble, and resuable) (3).
  • 2003 Mulder Nucl Acids Res {22

    2003 Mulder Nucl Acids Res {22

    The InterPro Database, 2003 brings increased coverage and new features Nicola J Mulder, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Daniel Barrell, Alex Bateman, David Binns, Margaret Biswas, Paul Bradley, Peer Bork, et al. To cite this version: Nicola J Mulder, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Daniel Barrell, et al.. The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Research, Oxford University Press, 2003, 31 (1), pp.315-318. 10.1093/nar/gkg046. hal-01214149 HAL Id: hal-01214149 https://hal.archives-ouvertes.fr/hal-01214149 Submitted on 9 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. # 2003 Oxford University Press Nucleic Acids Research, 2003, Vol. 31, No. 1 315–318 DOI: 10.1093/nar/gkg046 The InterPro Database, 2003 brings increased coverage and new features Nicola J. Mulder1,*, Rolf Apweiler1, Teresa K. Attwood3, Amos Bairoch4, Daniel Barrell1, Alex Bateman2, David Binns1, Margaret Biswas5, Paul Bradley1,3, Peer Bork6, Phillip Bucher7, Richard R. Copley8, Emmanuel Courcelle9, Ujjwal Das1, Richard Durbin2, Laurent Falquet7, Wolfgang Fleischmann1, Sam Griffiths-Jones2, Downloaded from Daniel Haft10, Nicola Harte1, Nicolas Hulo4, Daniel Kahn9, Alexander Kanapin1, Maria Krestyaninova1, Rodrigo Lopez1, Ivica Letunic6, David Lonsdale1, Ville Silventoinen1, Sandra E.
  • MPGM: Scalable and Accurate Multiple Network Alignment

    MPGM: Scalable and Accurate Multiple Network Alignment

    MPGM: Scalable and Accurate Multiple Network Alignment Ehsan Kazemi1 and Matthias Grossglauser2 1Yale Institute for Network Science, Yale University 2School of Computer and Communication Sciences, EPFL Abstract Protein-protein interaction (PPI) network alignment is a canonical operation to transfer biological knowledge among species. The alignment of PPI-networks has many applica- tions, such as the prediction of protein function, detection of conserved network motifs, and the reconstruction of species’ phylogenetic relationships. A good multiple-network align- ment (MNA), by considering the data related to several species, provides a deep understand- ing of biological networks and system-level cellular processes. With the massive amounts of available PPI data and the increasing number of known PPI networks, the problem of MNA is gaining more attention in the systems-biology studies. In this paper, we introduce a new scalable and accurate algorithm, called MPGM, for aligning multiple networks. The MPGM algorithm has two main steps: (i) SEEDGENERA- TION and (ii) MULTIPLEPERCOLATION. In the first step, to generate an initial set of seed tuples, the SEEDGENERATION algorithm uses only protein sequence similarities. In the second step, to align remaining unmatched nodes, the MULTIPLEPERCOLATION algorithm uses network structures and the seed tuples generated from the first step. We show that, with respect to different evaluation criteria, MPGM outperforms the other state-of-the-art algo- rithms. In addition, we guarantee the performance of MPGM under certain classes of net- work models. We introduce a sampling-based stochastic model for generating k correlated networks. We prove that for this model if a sufficient number of seed tuples are available, the MULTIPLEPERCOLATION algorithm correctly aligns almost all the nodes.
  • EMBL-EBI-Overview.Pdf

    EMBL-EBI-Overview.Pdf

    EMBL-EBI Overview EMBL-EBI Overview Welcome Welcome to the European Bioinformatics Institute (EMBL-EBI), a global hub for big data in biology. We promote scientific progress by providing freely available data to the life-science research community, and by conducting exceptional research in computational biology. At EMBL-EBI, we manage public life-science data on a very large scale, offering a rich resource of carefully curated information. We make our data, tools and infrastructure openly available to an increasingly data-driven scientific community, adjusting to the changing needs of our users, researchers, trainees and industry partners. This proactive approach allows us to deliver relevant, up-to-date data and tools to the millions of scientists who depend on our services. We are a founding member of ELIXIR, the European infrastructure for biological information, and are central to global efforts to exchange information, set standards, develop new methods and curate complex information. Our core databases are produced in collaboration with other world leaders including the National Center for Biotechnology Information in the US, the National Institute of Genetics in Japan, SIB Swiss Institute of Bioinformatics and the Wellcome Trust Sanger Institute in the UK. We are also a world leader in computational biology research, and are well integrated with experimental and computational groups on all EMBL sites. Our research programme is highly collaborative and interdisciplinary, regularly producing high-impact works on sequence and structural alignment, genome analysis, basic biological breakthroughs, algorithms and methods of widespread importance. EMBL-EBI is an international treaty organisation, and we serve the global scientific community.
  • Annual Scientific Report 2011 Annual Scientific Report 2011 Designed and Produced by Pickeringhutchins Ltd

    Annual Scientific Report 2011 Annual Scientific Report 2011 Designed and Produced by Pickeringhutchins Ltd

    European Bioinformatics Institute EMBL-EBI Annual Scientific Report 2011 Annual Scientific Report 2011 Designed and Produced by PickeringHutchins Ltd www.pickeringhutchins.com EMBL member states: Austria, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom. Associate member state: Australia EMBL-EBI is a part of the European Molecular Biology Laboratory (EMBL) EMBL-EBI EMBL-EBI EMBL-EBI EMBL-European Bioinformatics Institute Wellcome Trust Genome Campus, Hinxton Cambridge CB10 1SD United Kingdom Tel. +44 (0)1223 494 444, Fax +44 (0)1223 494 468 www.ebi.ac.uk EMBL Heidelberg Meyerhofstraße 1 69117 Heidelberg Germany Tel. +49 (0)6221 3870, Fax +49 (0)6221 387 8306 www.embl.org [email protected] EMBL Grenoble 6, rue Jules Horowitz, BP181 38042 Grenoble, Cedex 9 France Tel. +33 (0)476 20 7269, Fax +33 (0)476 20 2199 EMBL Hamburg c/o DESY Notkestraße 85 22603 Hamburg Germany Tel. +49 (0)4089 902 110, Fax +49 (0)4089 902 149 EMBL Monterotondo Adriano Buzzati-Traverso Campus Via Ramarini, 32 00015 Monterotondo (Rome) Italy Tel. +39 (0)6900 91402, Fax +39 (0)6900 91406 © 2012 EMBL-European Bioinformatics Institute All texts written by EBI-EMBL Group and Team Leaders. This publication was produced by the EBI’s Outreach and Training Programme. Contents Introduction Foreword 2 Major Achievements 2011 4 Services Rolf Apweiler and Ewan Birney: Protein and nucleotide data 10 Guy Cochrane: The European Nucleotide Archive 14 Paul Flicek:
  • Expert Review of Proteomics

    Expert Review of Proteomics

    Expert Review of Proteomics Editorial Advisory Panel Overseeing the editorial content and development of Expert Review of Proteomics is an Editorial Advisory Board, composed of many of the world's leading experts in the field, drawn from both research and academia. Albala JS, UC Davis School of Medicine, CA, USA Apweiler R, European Bioinformatics Institute, Cambridge, UK Dr Rolf Apweiler studied Biology with an emphasis on Molecular Biology and Biochemistry at the University of Heidelberg, Germany and the University of Bath, UK. He worked between 1991-1994 in drug discovery at Boehringer Mannheim and has been involved in the Swiss-Prot project since 1987. He co- ordinates the Swiss-Prot knowledgebase group at the EBI since 1994, and started the TrEMBL, InterPro, Proteome analysis and CluSTr projects at the EBI. Since autumn 2001 he is also in charge of the EMBL nucleotide sequence database and started in 2002 the merge of the Swiss-Prot and TrEMBL projects with the PIR to UniProt. Dr Apweiler is heading a team of currently 100 biologists and programmers responsible for the UniProt, InterPro, Proteome analysis, CluSTr and EMBL nucleotide sequence database projects at the EBI. Rolf Apweiler's main research interests are focused on integrating heterogenous functional genomic and proteomic data resources with the main protein and nucleotide sequence databases, and automation of classification and annotation of protein sequences. Blackburn J, Cambridge University, Cambridge, UK Professor Blackburn received a doctorate and an honours degree in chemistry from the University of Oxford. Following his Doctorate, Professor Blackburn carried out post-doctoral research with Professor Fersht at the Centre for Protein Engineering in Cambridge.
  • Multi-Platform Discovery of Haplotype-Resolved Structural Variation in Human Genomes

    Multi-Platform Discovery of Haplotype-Resolved Structural Variation in Human Genomes

    bioRxiv preprint doi: https://doi.org/10.1101/193144; this version posted June 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Multi-platform discovery of haplotype-resolved structural variation in human genomes Mark J.P. Chaisson1,2*, Ashley D. Sanders3*, Xuefang Zhao4,5*, Ankit Malhotra6†, David Porubsky7,8†, Tobias Rausch3†, Eugene J. Gardner9†, Oscar Rodriguez10†, Li Guo11†, Ryan L. Collins5†, Xian Fan14†, Jia Wen15†, Robert E. Handsaker16,42†, Susan Fairley17†, Zev N. Kronenberg1†, Xiangmeng Kong18†, Fereydoun Hormozdiari19,20†, Dillon Lee21†, Aaron M. Wenger22†, Alex Hastie23†, Danny Antaki24†, Peter Audano1, Harrison Brand5, Stuart Cantsilieris1, Han Cao25, Eliza Cerveira6, Chong Chen14, Xintong Chen9, Chen-Shan Chin22, Zechen Chong14, Nelson T. Chuang9, Christine C. Lambert22, Deanna M. Church26, Laura Clarke17, Andrew Farrell21, Joey Flores27, Timur Galeev18, David Gorkin35,36, Madhusudan Gujral24, Victor Guryev7, William Haynes Heaton26, Jonas Korlach22, Sushant Kumar18, Jee Young Kwon6,46, Jong Eun Lee28, Joyce Lee23, Wan-Ping Lee6, Sau Peng Lee31, Shantao Li13, Patrick Marks26, Karine Viaud-Martinez27, Sascha Meiers3, Katherine M. Munson1, Fabio Navarro18, Bradley J. Nelson1, Conor Nodzak15, Amina Noor24, Sofia Kyriazopoulou- Panagiotopoulou26, Andy Pang23, Yunjiang Qiu25,28, Gabriel Rosanio24, Mallory Ryan6, Adrian Stütz3, Diana C.J. Spierings7, Alistair Ward21, AnneMarie E. Welch1, Ming Xiao32, Wei Xu26, Chengsheng Zhang6, Qihui Zhu6, Xiangqun Zheng-Bradley17, Ernesto Lowy17, Sergei Yakneen3, Steven McCarroll16,42⊗, Goo Jun33⊗, Li Ding34⊗, Chong Lek Koh30⊗, Bing Ren35,36⊗, Paul Flicek17§⊗, Ken Chen14§⊗, Mark B.
  • UC Riverside UC Riverside Previously Published Works

    UC Riverside UC Riverside Previously Published Works

    UC Riverside UC Riverside Previously Published Works Title Structural genomics is the largest contributor of novel structural leverage. Permalink https://escholarship.org/uc/item/82z2z1fg Journal Journal of structural and functional genomics, 10(2) ISSN 1345-711X Authors Nair, Rajesh Liu, Jinfeng Soong, Ta-Tsen et al. Publication Date 2009-04-01 DOI 10.1007/s10969-008-9055-6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California J Struct Funct Genomics (2009) 10:181–191 DOI 10.1007/s10969-008-9055-6 Structural genomics is the largest contributor of novel structural leverage Rajesh Nair Æ Jinfeng Liu Æ Ta-Tsen Soong Æ Thomas B. Acton Æ John K. Everett Æ Andrei Kouranov Æ Andras Fiser Æ Adam Godzik Æ Lukasz Jaroszewski Æ Christine Orengo Æ Gaetano T. Montelione Æ Burkhard Rost Received: 15 November 2008 / Accepted: 8 December 2008 / Published online: 5 February 2009 Ó The Author(s) 2009. This article is published with open access at Springerlink.com Abstract The Protein Structural Initiative (PSI) at the US structures for protein sequences with no structural repre- National Institutes of Health (NIH) is funding four large- sentative in the PDB on the date of deposition). The scale centers for structural genomics (SG). These centers structural coverage of the protein universe represented by systematically target many large families without structural today’s UniProt (v12.8) has increased linearly from 1992 to coverage, as well as very large families with inadequate 2008; structural genomics has contributed significantly to structural coverage. Here, we report a few simple metrics the maintenance of this growth rate.
  • Interpro: the Integrative Protein Signature Database

    Interpro: the Integrative Protein Signature Database

    InterPro: the integrative protein signature database Sarah Hunter, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Alex Bateman, David Binns, Peer Bork, Ujjwal Das, Louise Daugherty, Lauranne Duquenne, et al. To cite this version: Sarah Hunter, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Alex Bateman, et al.. InterPro: the integrative protein signature database. Nucleic Acids Research, Oxford University Press, 2009, 37 (Database issue), pp.D211-D215. 10.1093/nar/gkn785. hal-01214141 HAL Id: hal-01214141 https://hal.archives-ouvertes.fr/hal-01214141 Submitted on 9 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Published online 21 October 2008 Nucleic Acids Research, 2009, Vol. 37, Database issue D211–D215 doi:10.1093/nar/gkn785 InterPro: the integrative protein signature database Sarah Hunter1,*, Rolf Apweiler1, Teresa K. Attwood2, Amos Bairoch3, Alex Bateman4, David Binns1, Peer Bork5, Ujjwal Das1, Louise Daugherty1, Lauranne Duquenne6, Robert D. Finn4, Julian Gough7, Daniel Haft8, Nicolas Hulo3, Daniel Kahn6, Elizabeth Kelly9, Aure´ lie Laugraud6, Ivica Letunic5, David Lonsdale1, Rodrigo Lopez1, Martin Madera7, John Maslen1, Craig McAnulla1, Jennifer McDowall1, Jaina Mistry4, Downloaded from Alex Mitchell1,2, Nicola Mulder9, Darren Natale10, Christine Orengo11, Antony F.
  • Speaker Biographies

    Speaker Biographies

    Speaker Biographies Dr Rolf Apweiler is Director of EMBL-EBI, together with Ewan Birney. He also is the current Director of Open Targets. Prior to this position he was Joint Associate Director, after many years of leading protein resources such as UniProt. Rolf has made major contributions to methods for the automatic annotation of proteins, making it possible to add relevant information to whole proteome sets. Rolf received his PhD from the University of Heidelberg in 1994, and has been at EMBL since 1987. Dr Haruki Nakamura is Professor Emeritus and Former Director of Institute for Protein Research, Osaka University. He founded the Protein Data Bank Japan (PDBj) in 2001 and worked as the PI, collaborating with the other wwPDB partners including PDBe-EBI. He now works at National Institute of Genetics, Mishima, as a Specially Appointed Professor. He is also engaged in promotion of the Japanese project for supporting innovative drug discovery and life science research (AMED-BINDS) as the program supervisor. Dr Kazuhisa Tsunoyama is the director of Analytics and Informatics group, Real World Informatics and Analytics function at Astellas Pharma Inc. He has ben working on bioinformatics research and medical big data analysis since joining the company. In 2010, he led participation in the EBI Industry Programme. He was a visiting researcher at Imperial College London, UK from 2006 to 2008 and he was seconded to Astellas US LLC from 2016 to 2017. Dr Dominic Clark is the Industry Programme Manager at EMBL- EBI. The Industry Programme is a subscription-based programme for global companies that make significant use of the data and resources provided by EMBL-EBI.